IE881815L - Production of proteins in active forms - Google Patents

Production of proteins in active forms

Info

Publication number
IE881815L
IE881815L IE881815A IE181588A IE881815L IE 881815 L IE881815 L IE 881815L IE 881815 A IE881815 A IE 881815A IE 181588 A IE181588 A IE 181588A IE 881815 L IE881815 L IE 881815L
Authority
IE
Ireland
Prior art keywords
proteins
production
active forms
host cells
source
Prior art date
Application number
IE881815A
Other versions
IE66334B1 (en
Inventor
Joseph John Patroni
Malcom Roy Brandon
Original Assignee
Rutland Plastics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutland Plastics filed Critical Rutland Plastics
Publication of IE881815L publication Critical patent/IE881815L/en
Publication of IE66334B1 publication Critical patent/IE66334B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for the recovery of proteins in a solubilized form from host cells including providing a source of host cells incorporating a synthesized or expressed protein; providing a source of at least one cationic surfactant; and treating the host cells with at least one cationic surfactant, in an amount sufficient to effect solubilization of the proteins.
IE181588A 1987-06-15 1988-06-15 Production of proteins in active forms IE66334B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (2)

Publication Number Publication Date
IE881815L true IE881815L (en) 1988-12-15
IE66334B1 IE66334B1 (en) 1995-12-27

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
IE181588A IE66334B1 (en) 1987-06-15 1988-06-15 Production of proteins in active forms

Country Status (14)

Country Link
US (1) US4992531A (en)
JP (1) JPS6447389A (en)
KR (1) KR0126767B1 (en)
CN (1) CN1032425C (en)
AT (1) ATE114156T1 (en)
AU (1) AU609824B2 (en)
CA (1) CA1305284C (en)
DE (1) DE3852116T2 (en)
DK (1) DK322188A (en)
ES (1) ES2065911T3 (en)
IE (1) IE66334B1 (en)
NO (1) NO882635L (en)
NZ (1) NZ225032A (en)
ZA (1) ZA884212B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (en) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 Novel method for protein purification using detergents
JP3279362B2 (en) * 1992-10-05 2002-04-30 井上 聰一 Diabetes judgment method and diabetes judgment device
JP3319812B2 (en) * 1993-04-05 2002-09-03 井上 聰一 Rheumatism determination method and rheumatism determination device
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CN1318443C (en) * 2000-05-16 2007-05-30 博尔德生物技术公司 Methods for refolding proteins containing free cysteine residues
CA2497560A1 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
EP1558748A4 (en) * 2002-11-01 2008-10-22 Promega Corp Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (en) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Recovery of soluble proteins from the biomass of recombinant microorganisms
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8188224B2 (en) 2005-04-11 2012-05-29 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US7811800B2 (en) 2005-04-11 2010-10-12 Savient Pharmaceuticals, Inc. Variant form of urate oxidase and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
JP2008545665A (en) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ Injectable superparamagnetic nanoparticles for hyperthermic treatment and use to form hyperthermic implants
EP1885875B1 (en) 2005-05-31 2019-05-22 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP2102355B1 (en) 2006-12-14 2016-03-02 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
JP5597200B2 (en) * 2008-08-18 2014-10-01 プロメガ コーポレイション Compounds producing luminescence and methods for detecting cytochrome P4503A enzyme
GB0901434D0 (en) 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
EP4635567A3 (en) 2009-06-25 2025-12-03 Horizon Therapeutics USA, Inc. Methods and kits for preventing infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
WO2011146595A2 (en) * 2010-05-21 2011-11-24 Siemens Healthcare Diagnostics Inc. Zwitterionic reagents
CN102965317A (en) * 2012-11-27 2013-03-13 江南大学 Method for screening taurine strains and method for producing taurine through fermenting strains
EP3099683B1 (en) 2014-01-29 2020-08-05 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3172332B1 (en) * 2014-07-22 2020-10-14 Bio-rad Laboratories, Inc. Buffers for use with polymerases
CN110234340A (en) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 Combination therapy of prednisone and uricase molecules and uses thereof
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
IE66334B1 (en) 1995-12-27
ZA884212B (en) 1989-03-29
CN88103725A (en) 1988-12-28
CA1305284C (en) 1992-07-14
AU1763288A (en) 1988-12-15
NO882635L (en) 1988-12-19
ATE114156T1 (en) 1994-12-15
DE3852116D1 (en) 1994-12-22
NZ225032A (en) 1991-02-26
ES2065911T3 (en) 1995-03-01
NO882635D0 (en) 1988-06-15
JPS6447389A (en) 1989-02-21
AU609824B2 (en) 1991-05-09
CN1032425C (en) 1996-07-31
DK322188D0 (en) 1988-06-14
DE3852116T2 (en) 1995-03-30
US4992531A (en) 1991-02-12
KR900000380A (en) 1990-01-30
DK322188A (en) 1988-12-17
KR0126767B1 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
IE881815L (en) Production of proteins in active forms
MY101204A (en) Solubilization of protein aggregates
AU6451786A (en) Thrombin preparations
SE8903777L (en) LIPOSOME / DOXORUBICIN, COMPOSITION AND PROCEDURE
IL91901A0 (en) Production of liposomes with improved stability during drying
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
AU1141288A (en) Production of proteins in active forms
IT8819077A0 (en) PROCESS FOR THE PREPARATION OF 1,2 DIFLUOROETHANE AND 1,1,2TRIFLUOROETHANE.
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
MY103362A (en) Production of proteins in active forms
AU7130791A (en) Vectors and compounds for expression of glycosylation mutants of human protein c
CA2090701A1 (en) Solubilization of proteins in active forms
EP0315118A3 (en) Dna coding for endothelin and use thereof
ZA857166B (en) Process for the extraction of stable camomile extracts which are rich in active agents
TR200002611T2 (en) Beta-lipotropin and its uses
MY103305A (en) Productions of proteins in active forms
FI853346A7 (en) Fragments and method for promoting 3' expression.
GR3003950T3 (en)
IL77152A0 (en) Expression vectors for protein production in e.coli and their production
JPS645712A (en) Method of finishing hollow double-wall structure
IT8421028V0 (en) AGRICULTURAL MACHINE STRUCTURE, IN PARTICULAR TO TREAT ARGINI AND SIMILAR.

Legal Events

Date Code Title Description
MM4A Patent lapsed